Enhancing Effectiveness of Immune Checkpoint Therapy in Neuroblastoma |
Children’s Hospital Los Angeles |
Northwestern Mutual Foundation |
CAMKV as a Target for Immunotherapy in MYCN-Amplified Neuroblastoma |
Children’s Hospital of Philadelphia |
Northwestern Mutual Foundation |
Targeting Secondary Mutations in Juvenile Myelomonocytic Leukemia |
University of California San Francisco |
Northwestern Mutual Foundation |
Novel Role of Hematopoietic Stem Cells in Immunologic Rejection of Malignant Pediatric Brain Tumors |
University of Florida |
Northwestern Mutual Foundation |
The YB1 Way of Surviving Radiation, Pediatric Brain Tumor Resistance and Recurrence |
Emory University |
Northwestern Mutual Foundation |
Engager T Cells: A Novel Immunotherapeutic for AML |
University of Michigan |
Northwestern Mutual Foundation |
Optimizing Engager T-cells for CD19+ Malignancies |
Baylor College of Medicine |
Northwestern Mutual Foundation |
Identification of Resistance Mechanisms and Novel Therapeutic Strategies in Tyrosine Kinase Inhibitor Resistant FLT3/ITD Acute Myeloid Leukemia |
Fred Hutchinson Cancer Research Center |
Northwestern Mutual Foundation |
Development of Targeted DNA-damaging Therapy for ATRX-deficient Pediatric Glioblastoma |
University of Michigan |
Northwestern Mutual Foundation |
A Developmental Model to Characterize the Epigenetic Origins of the Retinoblastoma Tumor Initiating Cell |
The Johns Hopkins University School of Medicine |
Northwestern Mutual Foundation |